Subodh Deshmukh

CEO Aragen Bioscience, Inc.

Subodh Deshmukh is an accomplished leader with over 23 years experience in biotechnology innovation that includes work on several lifesaving therapies such as Torisel®, Ibrance®, Bosulif®. Prior to Aragen, he was the Chief Development Officer of publicly traded Zymergen, where he was responsible for product development, manufacturing and program management.
Earlier in his career he has held various leadership roles including as the Global Head of product development at Sandoz (Novartis), at Sun Pharma as Senior Vice President of R&D and at Pfizer as Head of US Materials Science and Senior Director for Technology Operations.


  • PhD, Chemical Engineering, University of Pittsburgh
  • MBA, Wharton School, University of Pennsylvania